why choose us

First received: March 19, 2025

Clinical Trial: Carotegrast Methyl in Ulcerative Colitis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Ulcerative Colitis

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Carotegrast Methyl in Active Ulcerative Colitis: a Real-World Prospective Cohort Study

Brief Summary: Carotegrast methyl, an oral ?4-integrin inhibitor, was recently approved in Japan for the treatment of active ulcerative colitis (UC).However, real-world data regarding its efficacy and safety remain scarce.This study aimed to assess the clinical effectiveness and safety profile of carotegrast methyl in patients with active UC.

Read more